Who is sponsoring NCT05004467?

NCT05004467 is sponsored by Universidad Europea de Madrid.

What drugs are being tested in NCT05004467?

Interventions in NCT05004467: Mobilization With Movement Technique.

What condition does NCT05004467 study?

NCT05004467 studies Orthopedic Disorder of Spine, Placebo Effect, Disability Physical.

Is NCT05004467 still recruiting?

NCT05004467 is currently completed. Last updated 1 April 2022.

Last reviewed 2022-04-01 · How we verify

NCT05004467

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Predictive Effects of Mulligan Treatment in Patients With Chronic Neck Pain

Completed NA Last updated 1 April 2022

What this trial tests

NA trial testing Mobilization With Movement Technique in Orthopedic Disorder of Spine in 42 participants. Completed in 18 March 2022.

Timeline

2 August 2021

Primary endpoint
10 February 2022

18 March 2022

Quick facts

Lead sponsor	Universidad Europea de Madrid
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	42
Start date	2 August 2021
Primary completion	10 February 2022
Estimated completion	18 March 2022
Sites	1 location across Spain

Drugs / interventions tested

Mobilization With Movement Technique

Conditions studied

Orthopedic Disorder of Spine — all drugs for Orthopedic Disorder of Spine →
Placebo Effect — all drugs for Placebo Effect →
Disability Physical — all drugs for Disability Physical →

Sponsor

Universidad Europea de Madrid

Who can join

Adults 18 to 60, any sex, with Orthopedic Disorder of Spine or Placebo Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is the measurement and comparison of two manual therapy techniques, the Mulligan´s mobilization with movement technique, and de placebo technique, both applicated in patients with subacute neck pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prediction of Patient Satisfaction after Treatment of Chronic Neck Pain with Mulligan's Mobilization.
Fernández-Carnero J, Beltrán-Alacreu H, Arribas-Romano A, Cerezo-Téllez E, et al · · 2022 · cited 16× · PMID 36675997 · DOI 10.3390/life13010048

Verify or expand the search:

Other Universidad Europea de Madrid trials

Trials by the same sponsor.

NCT07506837 — Effects of an HABIT-ILE-Based Intervention in Children With Cerebral Palsy · NA · not yet recruiting
NCT07470268 — Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Panc · NA · not yet recruiting
NCT07494903 — Effects of Vibrational Therapy on Pelvic Floor Muscle Strength and Tone in Healthy Women · NA · not yet recruiting
NCT07524010 — Multi-Omics Characterization of Percutaneous Electrolysis in Low Back Pain · Phase 1 · enrolling by invitation
NCT07484776 — Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05004467 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Europea de Madrid
Last refreshed: 1 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05004467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing